[go: up one dir, main page]

ZA79964B - 2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders - Google Patents

2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders

Info

Publication number
ZA79964B
ZA79964B ZA79964A ZA79964A ZA79964B ZA 79964 B ZA79964 B ZA 79964B ZA 79964 A ZA79964 A ZA 79964A ZA 79964 A ZA79964 A ZA 79964A ZA 79964 B ZA79964 B ZA 79964B
Authority
ZA
South Africa
Prior art keywords
dialkoxybenzamides
intermediates
treatment
methods
pharmaceutical compositions
Prior art date
Application number
ZA79964A
Other languages
English (en)
Inventor
G Florvall
S Oegren
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of ZA79964B publication Critical patent/ZA79964B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA79964A 1978-03-23 1979-02-28 2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders ZA79964B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7803411A SE411118B (sv) 1978-03-23 1978-03-23 Ett forfarande for framstellning av 2,6-dialkoxibensamider med terapentiska egenskaper

Publications (1)

Publication Number Publication Date
ZA79964B true ZA79964B (en) 1980-06-25

Family

ID=20334412

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA79964A ZA79964B (en) 1978-03-23 1979-02-28 2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders

Country Status (26)

Country Link
US (1) US4232037A (de)
EP (1) EP0004831B1 (de)
JP (1) JPS585910B2 (de)
AT (1) AT374173B (de)
AU (1) AU525475B2 (de)
CA (1) CA1101873A (de)
CS (1) CS226183B2 (de)
DD (1) DD143605A5 (de)
DE (1) DE2964774D1 (de)
DK (1) DK157844C (de)
ES (1) ES478871A1 (de)
FI (1) FI73979C (de)
HK (1) HK77085A (de)
HU (1) HU177793B (de)
IE (1) IE48491B1 (de)
LT (1) LT2246B (de)
LU (1) LU88308I2 (de)
MX (1) MX9203148A (de)
MY (1) MY8500407A (de)
NL (1) NL930052I2 (de)
NO (1) NO152414C (de)
NZ (1) NZ189935A (de)
SE (1) SE411118B (de)
SG (1) SG51885G (de)
SU (1) SU818481A3 (de)
ZA (1) ZA79964B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
US4470977A (en) * 1981-06-04 1984-09-11 Adria Laboratories, Inc. Antiemetic and antipsychotic agents
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
SE8400478D0 (sv) * 1984-01-31 1984-01-31 Astra Laekemedel Ab Oxysalicylamido derivatives
US5240957A (en) * 1984-01-31 1993-08-31 Astra Lakemedel Akteibolag Oxysalicylamido derivatives
SE8503054D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Catecholcarboxamides
DE3629598A1 (de) * 1986-08-30 1988-03-03 Boehringer Ingelheim Kg 3-brom-2,6-dimethoxibenzamide, ihre herstellung und verwendung
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US5154913A (en) * 1987-11-19 1992-10-13 Vanderbilt University Radioiodinated benzamines method of their use as radioimaging agents
US5231099A (en) * 1991-04-15 1993-07-27 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
US5248817A (en) * 1991-07-15 1993-09-28 Merck & Co., Inc. Process for aromatic bromination
WO1993002036A1 (en) * 1991-07-15 1993-02-04 Merck & Co., Inc. Novel process for aromatic bromination
CN104058956A (zh) * 2014-06-04 2014-09-24 蚌埠团结日用化学有限公司 3-溴-2，6二甲氧基苯甲酸合成的生产工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD67123A (de) *
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (de) * 1966-01-21 1968-05-06
BE695272A (de) * 1967-03-09 1967-09-11
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
IT1070992B (it) * 1973-12-21 1985-04-02 Italfarmaco Spa Processo per la preparazione della i etil 2 2 metossi 5 sulfamoil benzamidometil pirrolidina
CH605793A5 (fr) * 1974-03-05 1978-10-13 Soc Et Scient Et Ind Procédé de préparation de nouveaux N-(1benzylpyrrollidinil 2-alkyl) benzamides substitués
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
EP0004831A3 (en) 1979-10-31
MX9203148A (es) 1992-07-01
NO152414B (no) 1985-06-17
LU88308I2 (fr) 1994-05-04
SG51885G (en) 1986-01-24
AU525475B2 (en) 1982-11-11
CS226183B2 (en) 1984-03-19
NL930052I2 (nl) 1994-01-03
SU818481A3 (ru) 1981-03-30
JPS585910B2 (ja) 1983-02-02
NL930052I1 (nl) 1993-09-01
DD143605A5 (de) 1980-09-03
US4232037A (en) 1980-11-04
NZ189935A (en) 1984-07-06
DK157844B (da) 1990-02-26
HK77085A (en) 1985-10-18
IE48491B1 (en) 1985-02-06
EP0004831A2 (de) 1979-10-17
SE411118B (sv) 1979-12-03
SE7803411L (sv) 1979-09-24
CA1101873A (en) 1981-05-26
DK157844C (da) 1990-07-30
JPS54154730A (en) 1979-12-06
AT374173B (de) 1984-03-26
HU177793B (en) 1981-12-28
MY8500407A (en) 1985-12-31
DE2964774D1 (en) 1983-03-24
FI790922A (fi) 1979-09-24
FI73979B (fi) 1987-08-31
LT2246B (lt) 1993-11-15
FI73979C (fi) 1987-12-10
ES478871A1 (es) 1979-07-01
ATA217779A (de) 1983-08-15
IE790630L (en) 1979-09-23
AU4521979A (en) 1979-09-27
NO790934L (no) 1979-09-25
NO152414C (no) 1985-09-25
EP0004831B1 (de) 1983-02-16
DK117779A (da) 1979-09-24

Similar Documents

Publication Publication Date Title
PH14287A (en) Naphthyridine derivatives,pharmaceutical compositions containing same and method of treatment thereof
GB2029218B (en) Pharmaceutical composition for treatment of cardiovascular disease
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
ZA79964B (en) 2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders
AU551900B2 (en) Anthralin compositions for treatment of skin diseases
IT8009551A0 (it) E-5-(2-alogenovinil-)-2'deossicitidine, loro metodo di preparazione e loro impiego per il trattamentodi malattie da virus
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
DE2963572D1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
IT7950138A0 (it) Composizione farmaceutica per il trattamento dei parkinsonismi
PH15720A (en) Hypolipidemic derivatives of 4,5-dihydro-4-oxo-furan-2-carboxylic acid,their pharmaceutical compositions and method of use
ZA792043B (en) Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
GR861529B (en) 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases
PT70039A (en) Process for preparation of 1(2,6-dihalobenzoyl)-3-(5-substituted-2-pyridinyl) ureias and their use as insecticides
PT74849B (en) Process for preparing new substituted 3-(parasubstituted) phenoxy-1-alkylamino-propanol-2-s and of pharmaceutical compositions containing the same
GB2013189B (en) Process for the preparation of 9 oxobenzomorphans and intermediates for use therein
IT7821264A0 (it) Composizione per il trattamento dell'asma.
GB2024223B (en) Process for the preparation of n,n'-disubstituted 2 - naphta - leneethan - imidamides and intermediates used therein
ZA806085B (en) Therapeutic compositions for treatment of glaucoma
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
DE2966925D1 (en) 4,4 dialkyl-4-sila-fatty acid amides, intermediates and process for their preparation and pharmaceutical compositions containing them
ZA796513B (en) Substituted 2-phenylamino-imidazolines-(2),having particular therapeutic properties,process for their preparation,and pharmaceutical compositions containing them
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them